Science-first biotech investor, striving to make an impact with great people. Partner at Versant Ventures; ex-McKinsey; and trained population geneticist.
With a $125 million financing, we’re honored and excited to have investors’ confidence as we develop therapies to expand the reach of #precisiononcology to more patients than ever before. nestedtx.com
Not only is our #team comprised of exceptional leaders in #PrecisionMedicine, but it’s also built on strong core values that connect us in our quest to help patients. Learn more about what a future with us could look like: nestedtx.com/careers